Skip to main content
SEOUL PHARMA CO.,LTD logo

SEOUL PHARMA CO.,LTD — Investor Relations & Filings

Ticker · 018680 ISIN · KR7018680009 KO Manufacturing
Filings indexed 151 across all filing types
Latest filing 2022-10-04 Legal Proceedings Report
Country KR South Korea
Listing KO 018680

About SEOUL PHARMA CO.,LTD

http://www.seoulpharmaceuticals.com/

Seoul Pharma Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products. The company specializes in innovative drug delivery systems, with a core competency in Orally Disintegrating Film (ODF) technology. Its product portfolio includes a wide range of prescription and over-the-counter medications. Key therapeutic areas cover cardiovascular and respiratory systems, as well as anti-infective agents such as antibacterials, antifungals, and antivirals. The company also produces vitamins and antibiotics, aiming to improve health outcomes through its cutting-edge technological capabilities.

Recent filings

Filing Released Lang Actions
회계처리기준위반행위로인한증권선물위원회의검찰고발등
Legal Proceedings Report Classification · 100% confidence The document is an official regulatory announcement regarding accounting violations, sanctions by the Securities and Futures Commission (SFC), and subsequent legal actions (prosecution) against Seoul Pharma. This falls under the category of regulatory actions and legal proceedings involving the company's compliance and governance, which is best classified as a Legal Proceedings Report (LTR).
2022-10-04 Korean
기타시장안내(상장적격성 실질심사 관련 안내)
Legal Proceedings Report Classification · 100% confidence The document is a short regulatory notice from the Korea Exchange regarding Seoul Pharma. It informs the market about the initiation of a 'substantive review of listing eligibility' due to accounting violations. Since it is a regulatory announcement regarding listing status and does not fit into specific categories like M&A or financial reports, it falls under the general regulatory filing category.
2022-10-04 Korean
주권매매거래정지(상장적격성 실질심사 대상 (사유발생))
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice regarding the suspension of stock trading for Seoul Pharma due to a review of listing eligibility. It does not fit into specific categories like M&A, dividends, or financial reports, and serves as a formal regulatory announcement from the exchange, making 'RNS' the most appropriate classification.
2022-10-04 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) regarding the adjustment of the conversion price for convertible bonds (CB) issued by Seoul Pharma. It details the change in conversion price, the number of convertible shares, and the underlying calculation methodology based on market price fluctuations. This type of disclosure is a standard capital structure update related to financing instruments, which falls under the 'Capital/Financing Update' category.
2022-09-27 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Seoul Pharma Co., Ltd., covering the period from January 1, 2022, to June 30, 2022. It contains detailed financial information, business operations, management discussions, and organizational structure, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-12 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the adjustment of the conversion price for convertible bonds (CB) issued by Seoul Pharma. It details the change in conversion price, the number of convertible shares, and the underlying reasons (market price decline). This type of disclosure regarding capital structure changes, specifically related to convertible debt instruments, falls under the 'Capital/Financing Update' category.
2022-06-27 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.